CABA
Cabaletta Bio Inc
NASDAQ: CABA · HEALTHCARE · BIOTECHNOLOGY
$2.78
-2.80% today
Updated 2026-04-29
Market cap
$328.40M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$1 – $4
Volume
2.2M
Cabaletta Bio Inc (CABA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1000.00 | $34.17M | $141.47M | $114.72M | $126.34M | $116.97M | $253.65M | $185.05M |
| Cash & equivalents | $1000.00 | $33.02M | $136.20M | $101.43M | $122.22M | $81.61M | $193.24M | $163.96M |
| Current assets | $1000.00 | $33.99M | $140.55M | $113.53M | $124.54M | $108.83M | $244.49M | $166.68M |
| Total liabilities | $250000.00 | $44.86M | $3.15M | $5.18M | $8.38M | $12.45M | $17.45M | $32.71M |
| Current liabilities | $250000.00 | $943000.00 | $3.15M | $5.18M | $8.38M | $9.49M | $15.99M | $27.09M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | $-249000.00 | $-10.69M | $138.32M | $109.54M | $117.96M | $104.52M | $236.20M | $152.34M |
| Retained earnings | $-250000.00 | $-12.45M | $-32.96M | $-66.30M | $-112.59M | $-165.56M | $-233.24M | $-349.10M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |